Annual CFF
$105.43 M
+$103.65 M+5829.58%
December 1, 2024
Summary
- As of March 10, 2025, FHTX annual cash flow from financing activities is $105.43 million, with the most recent change of +$103.65 million (+5829.58%) on December 1, 2024.
- During the last 3 years, FHTX annual CFF has risen by +$83.01 million (+370.28%).
- FHTX annual CFF is now -51.52% below its all-time high of $217.47 million, reached on December 31, 2020.
Performance
FHTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$4000.00
-$1.05 M-99.62%
December 1, 2024
Summary
- As of March 10, 2025, FHTX quarterly cash flow from financing activities is $4000.00, with the most recent change of -$1.05 million (-99.62%) on December 1, 2024.
- Over the past year, FHTX quarterly CFF has stayed the same.
- FHTX quarterly CFF is now -100.00% below its all-time high of $128.51 million, reached on December 31, 2020.
Performance
FHTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$105.43 M
-$182.00 K-0.17%
December 1, 2024
Summary
- As of March 10, 2025, FHTX TTM cash flow from financing activities is $105.43 million, with the most recent change of -$182.00 thousand (-0.17%) on December 1, 2024.
- Over the past year, FHTX TTM CFF has stayed the same.
- FHTX TTM CFF is now -51.52% below its all-time high of $217.47 million, reached on December 31, 2020.
Performance
FHTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
FHTX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5829.6% | 0.0% | 0.0% |
| 3 y3 years | +370.3% | -96.1% | +7018.7% |
| 5 y5 years | +339.9% | -96.1% | +7018.7% |
FHTX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +5880.0% | -100.0% | at low | -0.5% | >+9999.0% |
| 5 y | 5-year | -51.5% | +5880.0% | -100.0% | at low | -51.5% | >+9999.0% |
| alltime | all time | -51.5% | +5880.0% | -100.0% | at low | -51.5% | >+9999.0% |
Foghorn Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $105.43 M(+5829.6%) | $4000.00(-99.6%) | $105.43 M(-0.2%) |
| Sep 2024 | - | $1.05 M(-99.0%) | $105.61 M(-0.3%) |
| Jun 2024 | - | $103.21 M(+8743.7%) | $105.95 M(+3626.6%) |
| Mar 2024 | - | $1.17 M(+527.4%) | $2.84 M(+59.9%) |
| Dec 2023 | $1.78 M(+0.9%) | $186.00 K(-86.6%) | $1.78 M(+10.6%) |
| Sep 2023 | - | $1.39 M(+1246.6%) | $1.61 M(+190.3%) |
| Jun 2023 | - | $103.00 K(+1.0%) | $554.00 K(-62.6%) |
| Mar 2023 | - | $102.00 K(+537.5%) | $1.48 M(-16.0%) |
| Dec 2022 | $1.76 M | $16.00 K(-95.2%) | $1.76 M(-92.5%) |
| Sep 2022 | - | $333.00 K(-67.7%) | $23.49 M(-0.7%) |
| Jun 2022 | - | $1.03 M(+168.2%) | $23.66 M(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $384.00 K(-98.2%) | $22.74 M(+1.4%) |
| Dec 2021 | $22.42 M(-89.7%) | $21.74 M(+4205.0%) | $22.42 M(-82.6%) |
| Sep 2021 | - | $505.00 K(+355.0%) | $129.19 M(-23.8%) |
| Jun 2021 | - | $111.00 K(+79.0%) | $169.44 M(-22.0%) |
| Mar 2021 | - | $62.00 K(-100.0%) | $217.29 M(-0.1%) |
| Dec 2020 | $217.47 M(+807.3%) | $128.51 M(+215.3%) | $217.47 M(+144.5%) |
| Sep 2020 | - | $40.75 M(-15.0%) | $88.96 M(+84.5%) |
| Jun 2020 | - | $47.96 M(>+9900.0%) | $48.21 M(>+9900.0%) |
| Mar 2020 | - | $247.00 K | $247.00 K |
| Dec 2019 | $23.97 M(-53.7%) | - | - |
| Dec 2018 | $51.77 M | - | - |
FAQ
- What is Foghorn Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual CFF year-on-year change?
- What is Foghorn Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly CFF year-on-year change?
- What is Foghorn Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Foghorn Therapeutics?
- What is Foghorn Therapeutics TTM CFF year-on-year change?
What is Foghorn Therapeutics annual cash flow from financing activities?
The current annual CFF of FHTX is $105.43 M
What is the all time high annual CFF for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual cash flow from financing activities is $217.47 M
What is Foghorn Therapeutics annual CFF year-on-year change?
Over the past year, FHTX annual cash flow from financing activities has changed by +$103.65 M (+5829.58%)
What is Foghorn Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of FHTX is $4000.00
What is the all time high quarterly CFF for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly cash flow from financing activities is $128.51 M
What is Foghorn Therapeutics quarterly CFF year-on-year change?
Over the past year, FHTX quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Foghorn Therapeutics TTM cash flow from financing activities?
The current TTM CFF of FHTX is $105.43 M
What is the all time high TTM CFF for Foghorn Therapeutics?
Foghorn Therapeutics all-time high TTM cash flow from financing activities is $217.47 M
What is Foghorn Therapeutics TTM CFF year-on-year change?
Over the past year, FHTX TTM cash flow from financing activities has changed by $0.00 (0.00%)